Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
Start Date
10/31/2022
Completion Date
12/31/2027
Summary
This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.
Detailed Description
PRIMARY OBJECTIVES: I. Conduct a randomized, controlled trial evaluating the efficacy of a conversation tool on patient-centered health and decision-making outcomes among patients making lung cancer treatment decisions. A subset of participants from control and intervention groups will also have their clinic conversations with providers recorded II. Conduct in-depth, semi-structured qualitative audio or video recorded interviews among a subset of Aim 1 participants. OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I: Patients review decision aid. GROUP II: Patients receive standard of care. After completion of study intervention, patients are followed up at 2 weeks, 3 months, and 6 months.
Eligibility Criteria
Age Range: 18 years to 99 years
Interventions
Best Practice
Health Promotion and Education
Questionnaire Administration
Conditions
Locations
Hillsboro Medical Center
Hillsboro, Oregon 97123
United States
Adventist Health Portland
Portland, Oregon 97216
United States
OHSU Knight Cancer Institute
Portland, Oregon 97239
United States
Portland VA Medical Center
Portland, Oregon 97239
United States